4-cyclopropyl-5-[[5-[4-(2-ethyl-5-methyl-1H-imidazol-4-yl)phenyl]-2-methyl-1,2,4-triazol-3-yl]methyl]-1H-indazole
C26H27N7 — CID 157412606
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-cyclopropyl-5-[[5-[4-(2-ethyl-5-methyl-1H-imidazol-4-yl)phenyl]-2-methyl-1,2,4-triazol-3-yl]methyl]-1H-indazole
4-cyclopropyl-5-[[5-[4-(2-ethyl-5-methyl-1H-imidazol-4-yl)phenyl]-2-methyl-1,2,4-triazol-3-yl]methyl]-1H-indazole (PubChem CID 157412606) has the molecular formula C26H27N7 and a molecular weight of 437.55 g/mol. Its IUPAC name is 4-cyclopropyl-5-[[5-[4-(2-ethyl-5-methyl-1H-imidazol-4-yl)phenyl]-2-methyl-1,2,4-triazol-3-yl]methyl]-1H-indazole.
Molecular Properties
| Compound Name | 4-cyclopropyl-5-[[5-[4-(2-ethyl-5-methyl-1H-imidazol-4-yl)phenyl]-2-methyl-1,2,4-triazol-3-yl]methyl]-1H-indazole |
|---|---|
| PubChem CID | 157412606 |
| Molecular Formula | C26H27N7 |
| Molecular Weight | 437.55 g/mol |
| Exact Mass | 437.23 |
| IUPAC Name | 4-cyclopropyl-5-[[5-[4-(2-ethyl-5-methyl-1H-imidazol-4-yl)phenyl]-2-methyl-1,2,4-triazol-3-yl]methyl]-1H-indazole |
| SMILES | CCc1nc(-c2ccc(-c3nc(Cc4ccc5[nH]ncc5c4C4CC4)n(C)n3)cc2)c(C)[nH]1 |
| InChI | InChI=1S/C26H27N7/c1-4-22-28-15(2)25(29-22)17-7-9-18(10-8-17)26-30-23(33(3)32-26)13-19-11-12-21-20(14-27-31-21)24(19)16-5-6-16/h7-12,14,16H,4-6,13H2,1-3H3,(H,27,31)(H,28,29) |
| InChIKey | GHUYEKZWBDDPNG-UHFFFAOYSA-N |
| XLogP | 5.09 |
| TPSA | 88.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.55 |
| LogP ≤ 5 | 5.09 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157412606 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.